Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) (Q28280465)
scientific article
Language:
Current Data About Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
(P31) (Q13442814)

(P50) (Q54269356)
(P1932) Kim A Papp
(P1545) 1
(P248)

(Q6767705)
(P1545) 3
(P1932) Mark Lebwohl

(P304) 1675-84

(P407) (Q1860)

(P433) 9625

(P478) 371

(P577) Saturday, May 17, 2008

(P921) (Q269829)

(Q181600)

(Q194908)

(Q79460)
(P887)

(Q108853737)
(P887)

(Q422248)
(P887)

(P1433) (Q939416)

(P1476) "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)" (language: en)

(P2093) Richard G Langley
(P1545) 2

Gerald G Krueger
(P1545) 4

Philippe Szapary
(P1545) 5

Newman Yeilding
(P1545) 6

Cynthia Guzzo
(P1545) 7

Ming-Chun Hsu
(P1545) 8

Yuhua Wang
(P1545) 9

Shu Li
(P1545) 10

Lisa T Dooley
(P1545) 11

Kristian Reich
(P1545) 12

(P2860) (Q36742020)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q51008269)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q81716559)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q34575053)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q44525441)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q28280453)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q34577866)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q61853646)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q61853653)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q42627575)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q29396936)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q34690752)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q42495512)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q36166722)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q60711908)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q60711909)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q36461970)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

(Q42625315)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960726-6
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0140-6736(08)60726-6
(P698) 18486740
(P3181) 922858
(P5875) 5363251